Advanced Search
Contact | Corporate | Help

Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer

Sponsors:
  • Sidney Kimmel Comprehensive Cancer Center
  • American Cancer Society
  • Avon Foundation
  • Cancer Treatment Research Foundation
  • Commonwealth Foundation
  • Department of Defense
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Breast Neoplasms
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Biological: Allogeneic GM-CSF-secreting breast cancer vaccine
  • Drug: Trastuzumab
  • Drug: Cyclophosphamide
Enrollment:
20

Additional information about NCT00399529.


SourceSolution © 2008-2012